Home » Attend

Attend

8th PATIENT CENTRICITY & COLLABORATION WORLD CONGRESS 2026 EUROPE

A strategic approach prioritising the patient's needs, preferences, and values from drug development to treatment and beyond

Hilton London Kensington, London, UK

Tuesday 25th - Wednesday 26th February 2026

We are delighted to invite you to the 8th Patient Centricity and Collaboration World Congress 2026 Europe, hosted by Facilitate Live. This two-day Congress aims to foster meaningful collaborations among industry professionals, advocacy groups, clinicians, researchers, and, most importantly, patients and their caregivers. You will have the opportunity to acquire practical strategies and best practices for addressing challenges, embracing innovations, utilising new technologies, and implementing concepts that contribute to achieving patient-centric goals.

The congress theme, “A strategic approach prioritising the patient’s needs, preferences, and values from drug development to treatment and beyond,” underscores the critical importance of patient centricity and engagement in biopharmaceutical research and development, disease management, and the design of treatments, clinical trials, and other health solutions. True patient-centric solutions necessitate a collaborative endeavor with patients and their caregivers, involving their feedback and insights into medical conditions, experiences, needs, perspectives, and priorities.

Patient centricity necessitates a departure from traditional approaches, embracing diverse, patient centered perspectives. This involves several key aspects, beginning with patient-centric clinical trials and drug development, integrating patient insights into the design, evaluation, and manufacturing of therapeutic products. It also entails actively engaging patients in discussions and decisions concerning healthcare products and services. Patient centricity further emphasizes personalized care, tailoring treatments, communications, and support to individual patient needs. This is complemented by improved communication, fostering clear, transparent, and accessible interactions between healthcare professionals and patients. Ultimately, patient centricity extends to prioritizing patient well-being, acknowledging emotional, social, and financial considerations alongside medical conditions.

While technology-driven advancements present challenges, they also create opportunities to enhance the patient experience by coordinating the health ecosystem around the patient. This requires reevaluating drug development and delivery to improve experiences and outcomes, and continuously adapting to meet the evolving needs of patients.

The industry has made significant progress in adopting a patient centered approach, transforming the concept from a mere buzzword to a tangible goal. However, with the evolving healthcare model and ecosystem, driven by technological advancements and more engaged patients, achieving true patient centricity remains an ongoing quest and a steadfast commitment.

We look forward to meeting you at the Congress!

GAIN LATEST INSIGHTS ON:

  • Critical topics regarding patient centricity within the pharmaceutical and life sciences industry.
  • Why it’s imperative for our industry to fully embrace the patient-centric movement?
  • We will delve into several key areas that are vital for its successful implementation.
  • We will be exploring what patient centricity truly means for our sector.
  • Why it’s so crucial for the industry to actively participate in this shift?
  • Patient-centric initiatives that have already demonstrated a significant impact.
  • Successful strategies and best practices for managing patient centricity in healthcare.
  • How we can develop and execute effective strategies to improve patient engagement and the benefits this engagement brings to the drug development and discovery process.
  • Evolving challenges and key considerations in the ethical and compliant use of relevant data, and the potential value of providing access to this data to all stakeholders.
  • How we can maintain mutually beneficial ongoing partnerships between patients and the industry.
  • Overcoming the challenges in making clinical trials and drug development more patient-centered.
  • Setting expectations through collaborations
  • Understanding the role of researchers in bridging communication gaps.
  • This congress also focuses on practical strategies for developing a powerful brand with the patient at its core.

Co-located with the Decentralized & Hybrid Trials 2026 Europe 

WHO SHOULD ATTEND?

This Congress is beneficial to pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology and healthcare companies.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Leaders in the area of:

  • Patient Engagement
  • Patient Services
  • Engagement Strategy
  • R&D Patient Engagement
  • Medical Affairs
  • Commercialisation
  • Marketing
  • Regulatory Affairs and Policy
  • Patient Support
  • RWE, and Data Management
  • Quality and Compliance
  • Clinical Development and Operations
  • Programme Management
  • Supply Chain Management
  • Patient Access
  • Clinical Research
  • Digital Accelerator
  • Patient Engagement & Portfolio Strategy
  • Patient Support
  • Strategy & Insights
  • Patient Experience
  • Global Patient Advocacy & Alliances
  • Government Policy and Advocacy
  • Digital Patient Experience Lead
  • Clinical Insights and Experience
  • Head of Strategy, Access Services
  • Site Collaborations and Patient Centricity

Delegate Tickets

Group Discounts Are Also Available

Patients / Patient Group

Subject To Approval
Free
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Non Profit / Acedemic

Verification Required
£499
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Early Bird Discount -Vendor Registration Rate

Vendors / Service / Solution Providers / Consultants / CRO's
£1699
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Standard Vendor Registration Rate

Vendors / Service / Solution Providers / Consultants / CRO's
£1999
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Standard Registration Rate

Pharma / Biotech
£1299
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception
Scroll to Top
Update cookies preferences